NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/05/2020
Back to search
Official data from USPTO
LYMPH BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LYMPH BIOLOGICS
ST13
US500000085049083Class
44
Filing
85049083
Registration
3969199
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/05/2020
Trademark type
Word
Nice classes
44
Filing date
05/27/2010
Registration date
05/31/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2020
Last transaction
11/05/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/31/2002
First use in commerce
12/31/2002
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
FALK, ERIN
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Synergy Health Products Inc.
Representatives
Michael R. Gilman Kaplan Breyer Schwarz LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Alternative medical treatment serviceslymphatic drainage treatment activated through use of a three part light waveemitted in pulses of light waves movednon-invasivelyacross an affected areafor stress relieffatigue eliminationelimination of toxins in the bodyincreased circulationwaste drainageskin tone and texture enhancement and cellulite diminution
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/05/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/05/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/04/2020
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
11/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
09/15/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/31/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/01/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/01/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/01/2017
E815
TEAS SECTION 8 & 15 RECEIVED
05/08/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2011
PUBO
PUBLISHED FOR OPPOSITION
03/15/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2010
GNRT
NON-FINAL ACTION E-MAILED
10/01/2010
CNRT
NON-FINAL ACTION WRITTEN
10/01/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/24/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2010
DOCK
ASSIGNED TO EXAMINER
09/10/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/04/2010
NWAP
NEW APPLICATION ENTERED
05/31/2010
Continuous trademark protection
Get notified about every new filing that threatens LYMPH BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.